Protective effect of aprotinin against lung damage in patients undergoing CABG surgery

Acta Cardiologica

Volumn 60, Issue 4, 2005, Pages 367-372

  Erdogan, Mustafa ^a   Kalaycioglu, Sedat ^a,b   Iriz, Erkan ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b Gazi Hastanesi   (Turkey)

Author keywords

Aprotinin; Cardiopulmonary bypass; Lung injury

Indexed keywords

APROTININ; COMPLEMENT COMPONENT C4; MALONALDEHYDE; NITRIC OXIDE;

ADULT; ARTERIAL CARBON DIOXIDE TENSION; ARTERY CATHETER; ARTICLE; BLOOD GAS; BYPASS SURGERY; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LEUKOCYTE COUNT; LUNG BIOPSY; LUNG FUNCTION TEST; LUNG INJURY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD;

APROTININ; BIOPSY; BLOOD GAS ANALYSIS; CARDIOPULMONARY BYPASS; COMPLEMENT C3; COMPLEMENT C4; CORONARY ARTERY BYPASS; FEMALE; HEMOSTATICS; HUMANS; INFUSIONS, INTRA-ARTERIAL; LEUKOCYTE COUNT; LUNG; MALE; MALONDIALDEHYDE; MIDDLE AGED; NITRIC OXIDE; PULMONARY ARTERY; REPERFUSION INJURY; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY FUNCTION TESTS; SERINE PROTEINASE INHIBITORS; TREATMENT OUTCOME;

EID: 23644462687     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.60.4.2004984     Document Type: Article

References (20)

1. American College of Chest Physicians/Society of Critical Care Medicine consensus Conference: Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-8.
2. Byrick RJ, Noble WH. Post perfusion lung syndrome. Comparison of Travenol bubble and membrane oxygenators. J Thorac Cardiovasc Surg 1978; 76: 685-93.
3. Royston D. Systemic inflammatory response to surgery with cardiopulmonary bypass. Perfusion 1996; 11: 177-89.
4. Hall RJ, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic and pharmacological considerations. Anesth Analg 1997; 85: 766-82.
5. Kirklin JK, Blackstone EH, Kirklin JW. Cardiopulmonary bypass: studies on its damaging effects. Blood Purif 1987; 5: 168-78.
6. Kaiser L, Kron I, Sprayt. Mastery of cardiothoracic surgery. Technique of lung transplantation. New York, Lippincott-Raven, 1998: 61-92.
7. Wellbourn CR, Goldman G, Paterson IS, Valeri CR Shepro D, Hechtman HB. Pathophysiology of ischemia reperfusion injury: central role of the neutrophil. Br J Surg 1991; 78: 651-5.
8. Hill GE, Springall DR, Robbins RA. Aprotinin is associated with a decrease in nitric oxide production during cardiopulmonary bypass. Surgery 1997; 121: 449-55.
9. Gott JP, Cooper WA, Schmidt FE Jr, Brown WM, Wright CE, Merlino JD, Fortenberry JD, Clark WS, Guyton RA. Modifying risk for extracorporeal circulation: trial of four anti-inflammatory strategies. Ann Thorac Surg 1998; 66: 747-54.
10. Komai H, Hawort SG. The effect of cardiopulmonary bypass on the lung. In: Jonas RA, Elliott MJ, eds. Cardiopulmonary bypass in neonates, infants, and young children. Oxford: Butterworth-Heinemann Ltd., 1994: 242-62.
11. Takaaki S, Toyoki F, Tsutomu I, Yasunori C, Ichiro K. Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants. Ann Thorac Surg 2000; 69: 602-9.
12. Hachida M, Hanayama N, Okamura T, Akasawa T, Maeda T, Bonkohara Y, Endo M, Hashimoto A, Koyanagi H. The role of leukocyte depletion in reducing injury to myocardium and lung during cardiopulmonary bypass. ASAIO J 1995; 41: M291-4.
13. Ratliff NB, Young WG, Hackel DB, Mikat E, Wilson JM. Pulmonary injury secondary to extracorporeal circulation: An ultra structural study. J Thorac Cardiovasc Surg 1972; 65: 425-32.
14. Friedman M, Wang SY, Selike FW, Cohn WE, Weintraub RM, Johnson RG. Neutrophil adhesion blockade with NPC 15669 decreases pulmonary injury after total cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996; 111: 460-8.
15. Ali R, Bilal Ü, Oktay B, Ibrahim HÖ, Ahmet Ç, Mustafa KB. Does aprotinin reduce lung reperfusion damage after cardiopulmonary bypass? Eur J Cardiothorac Surg 2000; 18: 583-8.
16. Gu YJ, De Vries AJ, Vos P, Boonstra PW, Oeveren WV. Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit. Ann Thoracic Surg 1999; 67: 604-9.
17. Hill GE, Pohorecki R, Alonso A, Rennard SI, Robbins RA. Aprotinin reduces inteleukin-8 production and lung neutrophil accumulation after cardiopulmonary bypass. Anesth Analg 1996; 83: 696-700.
18. Kobzik L, Bredt DS, Lowenstein CJ, Drazen J, Gaston B, Sugarbaker D, Stamler JS. Nitric oxide synthesis in human and rat immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol; 1993; 9: 371-7.
19. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133-5.
20. Alican I, Kubes P. A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol 1996; 270: G225-37.